Dachaigh › Tumor Rhabdoid
Sgrùdaidhean clionaigeach Tumor Rhabdoid a’ fastadh anns na SA
Tha 17 sgrùdaidhean airson Tumor Rhabdoid a’ fastadh phàirtichean aig làraichean air feadh nan Stàitean Aonaichte.
Bailtean leis na sgrùdaidhean as motha
- Washington, DC5 sgrùdaidhean
- Houston, TX4 sgrùdaidhean
- St. Louis, MO3 sgrùdaidhean
- Birmingham, AL3 sgrùdaidhean
- Mountain View, CA3 sgrùdaidhean
Le stàit
- Alabama3 sgrùdaidhean
- California4 sgrùdaidhean
- Missouri3 sgrùdaidhean
- Sgìre Cholumbia5 sgrùdaidhean
- Tennessee3 sgrùdaidhean
- Texas6 sgrùdaidhean
Sgrùdaidhean air an ùrachadh o chionn ghoirid
Teacsa sgrùdaidh oifigeil (Beurla)
GPC2-CAR T Cell Therapy for Relapsed or Refractory Medulloblastoma in Children and Young Adults
A’ fastadhÌre 1
Aoisean 1 gu 30 · Gach gnè · Air ùrachadh 11 Sult 2026 · NCT07087002NgFUS NIVO: NeuroNavigation-Guided Focused Ultrasound With Nivolumab in Relapsed and Progressive DMG and Other High Grade Brain Tumors
A’ fastadhÌre 1
Aoisean 3 gu 25 · Gach gnè · Air ùrachadh 9 Sult 2026 · NCT07664176HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
A’ fastadhÌre 1
36 Months – 22 Years · Gach gnè · Air ùrachadh 4 Sult 2026 · NCT03911388Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
A’ fastadhÌre 1/2
Suas gu aois 26 · Gach gnè · Air ùrachadh 3 Sult 2026 · NCT06465199B7-H3.CD28Z.CART in CNS Neoplasms
A’ fastadhÌre 1
Aoisean 2 gu 21 · Gach gnè · Air ùrachadh 3 Sult 2026 · NCT07390539Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors
A’ fastadhÌre 1
Aoisean 1 gu 21 · Gach gnè · Air ùrachadh 6 Lùna 2026 · NCT04715191C7R-GD2.CAR T Cells for Patients With GD2-expressing Brain Tumors (GAIL-B)
A’ fastadhÌre 1
12 Months – 25 Years · Gach gnè · Air ùrachadh 3 Lùna 2026 · NCT04099797Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors
A’ fastadhÌre 1/2
6 Months – 25 Years · Gach gnè · Air ùrachadh 30 Ògmh 2026 · NCT06625190Study of Novel Therapies for Young People With Recurrent/Progressive Atypical Teratoid Rhabdoid Tumor (ATRT)
A’ fastadhÌre 2
Aoisean 1 gu 39 · Gach gnè · Air ùrachadh 23 Ògmh 2026 · NCT07447076Immunotherapy for Malignant Pediatric Brain Tumors Employing Adoptive Cellular Therapy (IMPACT)
A’ fastadhÌre 1
Aoisean 1 gu 30 · Gach gnè · Air ùrachadh 17 Ògmh 2026 · NCT06193759B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)
A’ fastadhÌre 1
Suas gu aois 21 · Gach gnè · Air ùrachadh 19 Cèit 2026 · NCT04897321Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma
A’ fastadhÌre 1/2
12 Months – 30 Years · Gach gnè · Air ùrachadh 19 Cèit 2026 · NCT04901702A Study of Selinexor in People With Wilms Tumors and Other Solid Tumors
A’ fastadhÌre 2
12 Months · Gach gnè · Air ùrachadh 6 Cèit 2026 · NCT05985161Study of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Midline Glioma and Recurrent or Refractory Pediatric Central Nervous System Tumors
A’ fastadhÌre 1
Aoisean 1 gu 26 · Gach gnè · Air ùrachadh 13 Gibl 2026 · NCT04185038Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor T Cells
A’ fastadhÌre 1
Aoisean 1 gu 26 · Gach gnè · Air ùrachadh 17 Gearr 2026 · NCT07148050Immunotherapy For Adults With GPC3-Positive Solid Tumors Using IL-15 and IL-21 Armored GPC3-CAR T Cells
A’ fastadhÌre 1
Suas gu aois 21 · Gach gnè · Air ùrachadh 3 Samh 2025 · NCT06198296A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors
A’ fastadhÌre 2
18 Months – 40 Years · Gach gnè · Air ùrachadh 12 Lùna 2025 · NCT05135975Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.